Allyl isothiocyanate induces replication-associated DNA damage response in NSCLC cells and sensitizes to ionizing radiation

被引:39
作者
Tripathi, Kaushlendra [1 ]
Hussein, Usama K. [1 ,2 ]
Anupalli, Roja [1 ,3 ]
Barnett, Reagan [1 ]
Bachaboina, Lavanya [1 ]
Scalici, Jennifer [1 ]
Rocconi, Rodney P. [1 ]
Owen, Laurie B. [1 ]
Piazza, Gary A. [1 ]
Palle, Komaraiah [1 ]
机构
[1] Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, Mobile, AL 36688 USA
[2] Beni Suef Univ, Fac Sci, Bani Suwayf, Egypt
[3] Osmania Univ, Dept Genet, Hyderabad 500007, Andhra Pradesh, India
关键词
Dietary isothiocyanates; replication stress; DNA damage response; radiosensitization; non-small cell lung cancer; CRUCIFEROUS VEGETABLE INTAKE; PROSTATE-CANCER CELLS; LUNG-CANCER; PHENETHYL ISOTHIOCYANATE; TOPOISOMERASE-I; BLADDER-CANCER; APOPTOSIS; GROWTH; DRUGS; PATHWAY;
D O I
10.18632/oncotarget.3026
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Allyl isothiocyanate (AITC), a constituent of many cruciferous vegetables exhibits significant anticancer activities in many cancer models. Our studies provide novel insights into AITC-induced anticancer mechanisms in human A549 and H1299 non-small cell lung cancer (NSCLC) cells. AITC exposure induced replication stress in NSCLC cells as evidenced by gamma H2AX and FANCD2 foci, ATM/ATR-mediated checkpoint responses and S and G2/M cell cycle arrest. Furthermore, AITC-induced FANCD2 foci displayed co-localization with BrdU foci, indicating stalled or collapsed replication forks in these cells. Although PITC (phenyl isothiocyanate) exhibited concentration-dependent cytotoxic effects, treatment was less effective compared to AITC. Previously, agents that induce cell cycle arrest in S and G2/M phases were shown to sensitize tumor cells to radiation. Similar to these observations, combination therapy involving AITC followed by radiation treatment exhibited increased DDR and cell killing in NSCLC cells compared to single agent treatment. Combination index (CI) analysis revealed synergistic effects at multiple doses of AITC and radiation, resulting in CI values of less than 0.7 at Fa of 0.5 (50% reduction in survival). Collectively, these studies identify an important anticancer mechanism displayed by AITC, and suggest that the combination of AITC and radiation could be an effective therapy for NSCLC.
引用
收藏
页码:5237 / 5252
页数:16
相关论文
共 53 条
[1]   Nuclear factor-kappaB sensitizes to benzyl isothiocyanate-induced antiproliferation in p53-deficient colorectal cancer cells [J].
Abe, N. ;
Hou, D-X ;
Munemasa, S. ;
Murata, Y. ;
Nakamura, Y. .
CELL DEATH & DISEASE, 2014, 5 :e1534-e1534
[2]   Thresholds of replication stress signaling in cancer development and treatment [J].
Bartek, Jiri ;
Mistrik, Martin ;
Bartkova, Jirina .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2012, 19 (01) :5-7
[3]   Critical update and emerging trends in epidermal growth factor receptor targeting in cancer [J].
Baselga, J ;
Arteaga, CL .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (11) :2445-2459
[4]   The principal urinary metabolite of allyl isothiocyanate, N-acetyl-S-(N-allylthiocarbamoyl)cysteine, inhibits the growth and muscle invasion of bladder cancer [J].
Bhattacharya, Arup ;
Li, Yun ;
Geng, Feng ;
Munday, Rex ;
Zhang, Yuesheng .
CARCINOGENESIS, 2012, 33 (02) :394-398
[5]   Concurrent systemic therapy with radiotherapy for the treatment of poor-risk patients with unresectable stage III non-small-cell lung cancer: a review of the literature [J].
Cardenal, F. ;
Nadal, E. ;
Jove, M. ;
Faivre-Finn, C. .
ANNALS OF ONCOLOGY, 2015, 26 (02) :278-288
[6]   FANCD2-Controlled Chromatin Access of the Fanconi-Associated Nuclease FAN1 Is Crucial for the Recovery of Stalled Replication Forks [J].
Chaudhury, Indrajit ;
Stroik, Daniel R. ;
Sobeck, Alexandra .
MOLECULAR AND CELLULAR BIOLOGY, 2014, 34 (21) :3939-3954
[7]  
Chen Allan Y, 2004, Discov Med, V4, P208
[8]   DNA topoisomerase I drugs and radiotherapy for lung cancer [J].
Chen, Allan Y. ;
Chen, Patricia M. T. ;
Chen, Yi-Jen .
JOURNAL OF THORACIC DISEASE, 2012, 4 (04) :390-397
[9]   IMPACT OF TREATING FACILITIES' VOLUME ON SURVIVAL FOR EARLY-STAGE LARYNGEAL CANCER [J].
Chen, Amy Y. ;
Pavluck, Alex ;
Halpern, Michael ;
Ward, Elizabeth .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2009, 31 (09) :1137-1143
[10]  
Chen AY, 1997, CANCER RES, V57, P1529